Insulin Not the Killer in ACCORD

ADA 2013 — CHICAGO — Higher insulin use doesn't account for the higher mortality risk with intensive glucose management in the ACCORD trial, a study found, although whether those results were reassuring for the clinic was subject to debate.


< Back to Listings